|
Development of a postoperative nomogram to predict overall survival in gastric cancer using variables the AJCC recommends for collection and registration. |
| |
|
Honoraria - Intuitive Surgical; Johnson & Johnson; Kaken Pharmaceutical; Medtronic |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Boehringer Ingelheim; Exosome Diagnostics; GlaxoSmithKline; Merck; Novartis; Renalytix AI; Stratify Genomics |
Research Funding - Bayer (Inst); Celgene (Inst); Novo Nordisk (Inst); Otsuka (Inst) |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Johnson & Johnson |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Johnson & Johnson/Janssen; Nippon Covidien |
| |
|
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson; Lilly; Medtronic; Olympus; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda; Yakult Honsha |
Research Funding - Ono Pharmaceutical (Inst) |